国际医药卫生导报 ›› 2022, Vol. 28 ›› Issue (8): 1176-1179.DOI: 10.3760/cma.j.issn.1007-1245.2022.08.034

• 综述 • 上一篇    下一篇

藤梨根在恶性肿瘤中的研究进展

周明轩  李建厂   

  1. 滨州医学院附属医院儿童血液与内分泌科,滨州 256603

  • 收稿日期:2021-12-16 出版日期:2022-04-15 发布日期:2022-05-09
  • 通讯作者: 李建厂,Email:lijianchang111@163.com

Research progress of Actinidia chinensis root against malignant tumors

Zhou Mingxuan, Li Jianchang   

  1. Department of Pediatric Hematology and Endocrinology, Affiliated Hospital of Binzhou Medical University, Binzhou 256603, China

  • Received:2021-12-16 Online:2022-04-15 Published:2022-05-09
  • Contact: Li Jianchang, Email: lijianchang111@163.com

摘要: 藤梨根是一味常见的且具有多种功效的中药。据研究证明藤梨根具有抗肿瘤功效,现被广泛应用于各种肿瘤的治疗中。本文结合藤梨根提取物及成分对抗各种恶性肿瘤研究及机制探讨方面展开综述,为临床利用藤梨根防治肿瘤提供新的研究基础。

关键词: 藤梨根, 中药, 抗肿瘤, 综述

Abstract: Actinidia chinensis root is a common traditional Chinese medicine with multiple functions. It has been proved that Actinidia chinensis root has anti-tumor effect and is now widely used in the treatment of various tumors. This paper reviewed the researches on the mechanism of Actinidia chinensis root against various malignant tumors to provide a new research basis for clinical use of Actinidia chinensis root to prevent and treat tumors.

Key words: Actinidia chinensis root, Traditional Chinese medicine, Anti-tumor, Review